AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591
Ryan Allway June 4th, 2021 – Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients – Phase 2 Trial Underway NEW YORK, June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )